Identification of the calcitonin receptor in osteoarthritic chondrocytes
Open Access
- 13 October 2011
- journal article
- Published by Springer Science and Business Media LLC in BMC Research Notes
- Vol. 4 (1), 407
- https://doi.org/10.1186/1756-0500-4-407
Abstract
Preclinical and clinical studies have shown that salmon calcitonin has cartilage protective effects in joint degenerative diseases, such as osteoarthritis (OA). However, the presence of the calcitonin receptor (CTR) in articular cartilage chondrocytes is yet to be identified. In this study, we sought to further investigate the expression of the CTR in naïve human OA articular chondrocytes to gain further confirmation of the existents of the CTR in articular cartilage. Total RNA was purified from primary chondrocytes from articular cartilage biopsies from four OA patients undergoing total knee replacement. High quality cDNA was produced using a dedicated reverse transcription polymerase chain reaction (RT-PCR) protocol. From this a nested PCR assay amplifying the full coding region of the CTR mRNA was completed. Western blotting and immunohistochemistry were used to characterize CTR protein on protein level in chondrocytes. The full coding transcript of the CTR isoform 2 was identified in all four individuals. DNA sequencing revealed a number of allelic variants of the gene including two potentially novel polymorphisms: a frame shift mutation, +473del, producing a shorter form of the receptor protein, and a single nucleotide polymorphism in the 3' non coding region of the transcript, +1443 C>T. A 53 kDa protein band, consistent with non-glycosylated CTR isoform 2, was detected in chondrocytes with a similar size to that expressed in osteoclasts. Moreover the CTR was identified in the plasma membrane and the chondrocyte lacuna of both primary chondrocytes and OA cartilage section. Human OA articular cartilage chondrocytes do indeed express the CTR, which makes the articular a pharmacological target of salmon calcitonin. In addition, the results support previous findings suggesting that calcitonin has a direct anabolic effect on articular cartilage.Keywords
This publication has 44 references indexed in Scilit:
- Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnoverOsteoarthritis and Cartilage, 2011
- Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase–mediated cartilage degradation, but not aggrecanase‐mediated cartilage degradationArthritis & Rheumatism, 2007
- Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral bloodJournal of Bone and Mineral Metabolism, 2006
- Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritisArthritis & Rheumatism, 2006
- A New Type of Human Calcitonin Receptor Isoform Generated by Alternative SplicingBiochemical and Biophysical Research Communications, 1995
- The human calcitonin receptor gene (CALCR) at 7q21.3 is outside the deletion associated with the Williams syndromeCytogenetic and Genome Research, 1995
- Molecular cloning of two receptors from rat brain with high affinity for salmon calcitoninFEBS Letters, 1993
- Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitoninEndocrinology, 1992
- Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in cultureFEBS Letters, 1989
- Calcitonin and parathyroid‐hormone stimulation of acid mucopolysaccharide synthesis in cultured chondrocytes isolated from growth cartilageFEBS Letters, 1976